News from qiming venture partners A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jul 24, 2022, 23:55 ET Qiming's Portfolio Company InventisBio Lists on STAR Market

Qiming Venture Partners' portfolio company InventisBio (SHSE: 688382), a leading company in innovative drug development, today listed on the Science...

Jul 10, 2022, 21:00 ET Qiming Venture Partners Announces Closing of Funds Totaling US$3.2 Billion

Qiming Venture Partners announced today the closing of its latest funds totaling US$3.2 billion, including USD Fund VIII at US$2.5 billion and the...

Apr 12, 2022, 21:20 ET Qiming's Nisa Leung, Duane Kuang Named on 2022 Forbes Midas List

SHANGHAI, April 12, 2022 /PRNewswire/ – Forbes released the 2022 Midas List on April 12, a ranking of the world's top 100 venture capitalists. Nisa...

Mar 29, 2022, 22:18 ET Qiming's Portfolio Company Rendu Biotechnology Lists on STAR Market

Qiming Venture Partners' portfolio company Rendu Biotechnology (SESH: 688193), a leader in RNA molecular diagnostics in China, today listed on the...

Mar 22, 2022, 00:08 ET Qiming's Portfolio Company Arrail Group Lists on Main Board of HKEX

Qiming Venture Partners' portfolio company Arrail Group (SEHK: 06639), a leading dental services provider in China, today listed on the main board of ...

Mar 01, 2022, 20:00 ET Qiming Venture Partners Welcomes David Chu as IR Partner

Qiming Venture Partners, a leading venture capital firm in China, is pleased to announce that David Chu has joined the firm as a Partner, focusing on ...

Jan 07, 2022, 03:06 ET Qiming Venture Partners Announces Annual Promotions

Qiming Venture Partners, a leading venture capital firm in China, is pleased to announce the promotions of Bonnie Wang and Dr. Kan Chen to Partner,...

Jan 03, 2022, 23:06 ET Shiyu Wang Rejoins Qiming Venture Partners as Partner, Co-Leads TMT Team

Qiming Venture Partners, a leading venture capital firm in China, is pleased to announce that Shiyu Wang has rejoined the firm as a Partner. Shiyu...

Dec 10, 2021, 00:46 ET Qiming's Portfolio Company CANbridge Pharmaceuticals Lists on Main Board of HKEx

Qiming Venture Partners' portfolio company CANbridge Pharmaceuticals (SEHK: 1228), a leading China-based global rare disease-focused...

Nov 15, 2021, 01:50 ET Qiming's Portfolio Company Aohua Endoscopy Lands on STAR Market

Qiming Venture Partners' portfolio company Aohua Endoscopy (SHSE: 688212), a leading medical endoscope manufacturer, today landed on the STAR Market. ...

Oct 19, 2021, 01:46 ET Qiming's Portfolio Company Microtech Medical Lists on Main Board of HKEx

Qiming Venture Partners' portfolio company Microtech Medical (SEHK:2236), a leading Chinese diabetes management medical device maker, today listed on ...

Oct 14, 2021, 23:55 ET Qiming's Portfolio Company Abbisko Lists on Main Board of HKEx

Qiming Venture Partners' portfolio company Abbisko (SEHK:2256), a clinical-stage biopharmaceutical company, listed on the main board of the Hong Kong ...

Sep 24, 2021, 02:02 ET Qiming's Portfolio Company Broncus Lists on Main Board of HKEx

Qiming Venture Partners' portfolio company Broncus (SEHK:2216), a pioneer in China's interventional pulmonology navigation device market, today...

Aug 16, 2021, 02:07 ET Qiming's Portfolio Company Sino Biological Lists on Shenzhen's ChiNext Market

Qiming Venture Partners' portfolio company Sino Biological (SZSE: 301047) on August 16th listed on Shenzhen's ChiNext Market. The issue price is CNY...

Apr 28, 2021, 06:23 ET Qiming's Portfolio Company Fanli.com Goes Public on Shanghai Stock Exchange

Qiming's portfolio company Fanli.com went public today on Shanghai Stock Exchange via a reverse merger with Jiangxi Changjiu Biochemical (SHSE:...

Apr 13, 2021, 08:52 ET Qiming's Duane Kuang, Nisa Leung Named on 2021 Forbes Midas List

Forbes today released the 2021 Midas List, a ranking of the world's top 100 venture capitalists. Duane Kuang and Nisa Leung, Managing Partners of...

Mar 26, 2021, 22:13 ET Qiming's Portfolio Company Zhihu Lists on New York Stock Exchange

Qiming Venture Partners' portfolio company Zhihu (NYSE: ZH) on March 26th EST listed on the New York Stock Exchange. The issue price is US$9.5/ADS....

Mar 19, 2021, 21:00 ET Qiming's Portfolio Company Connect Biopharma Lists on Nasdaq

Qiming Venture Partners' portfolio company Connect Biopharma today listed on the Nasdaq with the stock code "CNTB". The issue price is US$ 17.00/ADS. ...

Feb 17, 2021, 22:59 ET First Cancer Early Screening Company Listed on HKEX as New Horizon Health Debuts

Qiming's portfolio company New Horizon Health (SEHK:6606) officially listed on the Main Board of Hong Kong Stock Exchange (HKEx) today. This is the...

Jan 25, 2021, 21:07 ET Qiming Venture Partners Closes RMB Fund VI at RMB 2.852 billion

Qiming Venture Partners ("Qiming") today announced the final close of our RMB Fund VI at RMB 2.852 billion. Currently, Qiming has $5.9 billion in...

Jan 07, 2021, 02:58 ET Qiming Venture Partners' Portfolio Company APT Medical Listed on STAR Board of Shanghai Stock Exchange

Qiming Venture Partners' portfolio company APT Medical (SHSE: 688617) today successfully listed on the Science and Technology Innovation Board (the...

Nov 20, 2020, 00:34 ET Qiming's Portfolio Company Antengene Lists on Main Board of HKEX

Qiming's portfolio company Antengene (SEHK: 6996) officially listed on the Main Board of The Stock Exchange of Hong Kong Limited today. The issue...

Nov 18, 2020, 08:10 ET Qiming Venture Partners Announces Final Closing of US$ 1.2 Billion Fund VII

Qiming Venture Partners today announced the final closing of Qiming Venture Partners Fund VII, a $1.2 billion fund focuses on early-stage Healthcare...

Sep 27, 2020, 23:21 ET Qiming's Portfolio Company Zai Lab Lists on Main Board of HKEX

Qiming's portfolio company Zai Lab (SEHK:9688, NASDAQ:ZLAB), an innovative commercial-stage biopharmaceutical company, officially listed on the Main...

Jun 28, 2020, 23:47 ET Qiming's Portfolio Company Gan & Lee Pharmaceuticals Lands A-Shares Main Board

Chinese insulin manufacturer Gan & Lee Pharmaceuticals (SHSE: 603087), Qiming's portfolio company today lands on the A-shares main board market. The...